Abraham B Beckers (Abraham Beckers, Bram Beckers, A B Beckers)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Irritable Bowel Syndrome

Ulcerative Colitis

Spectrum Disorder

Top Venues

Alimentary pharmacology & therapeutics

Therapeutic advances in gastroenterology

Pharmaceuticals (Basel, Switzerland)

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Keszthelyi, Abraham B Beckers
Technical advances allow in-depth understanding of the gut-brain interaction-yet important caveats remain. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 34 (11) (2022)
Abraham B Beckers, Johanna T W Snijkers, Zsa Zsa R M Weerts, Lisa Vork, Tim Klaassen, Fabiënne G M Smeets, Adrian A M Masclee, Daniel Keszthelyi
Digital Instruments for Reporting of Gastrointestinal Symptoms in Clinical Trials: Comparison of End-of-Day Diaries Versus the Experience Sampling Method. JMIR formative research 5 (11) (2021)
Abraham B Beckers, Lisa Vork, Asma Fikree, Rogier de Ridder, Qasim Aziz, Ad Masclee, Daniel Keszthelyi
Colonoscopy is safe and not associated with higher pain scores in patients with hypermobility spectrum disorder: results from an exploratory prospective study. Therapeutic advances in gastroenterology 13 (2020)
Kata Csekő, Abraham B Beckers, Daniel Keszthelyi, Zsuzsanna Helyes
Role of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets? Pharmaceuticals (Basel, Switzerland) 12 (2) (2019)
Abraham B Beckers, Z Z R M Weerts, A A M Masclee, D Keszthelyi
Letter: the neglected analgesic properties of red pepper in the clinical management of the irritable bowel syndrome pain-Authors' reply. Alimentary pharmacology & therapeutics 47 (1) (2017)
Abraham B Beckers, Z Z R M Weerts, Z Helyes, A A M Masclee, D Keszthelyi
Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome. Alimentary pharmacology & therapeutics 46 (10) (2017)